Hematopoietic stem cell transplantation for rheumatic diseases. Part 2: Brazilian experience and future prospectives;Transplante de células-tronco hematopoéticas em doenças reumáticas. Parte 2: Experiência Brasileira e perspectivas futuras

Revista Brasileira de Reumatologia

Volumn 45, Issue 5, 2005, Pages 301-312

  Voltarelli, Júlio C ^a   Stracieri, Ana Beatriz P L ^a   Oliveira, Maria Carolina B ^a   Godoi, Dannielle F ^a   Moraes, Daniela A ^a   Pieroni, Fabiano ^a   Malmegrim, Kelen C R ^a   Coutinho, Marina A ^a   Simões, Belinda P ^a   Massumoto, Celso ^a,b   Hamerschlak, Nelson ^a,c   Scheinberg, Morton ^a,c   Ferreira, Eurípides ^c,d,e   Coutinho, Mariana ^f   Ostronoff, Maurício ^f   Sturaro, Daniel ^a   Dulley, Frederico ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f Real Hospital Portugues   (Brazil)

Author keywords

Bone marrow transplantation; Hematopoietic stem cells; Rheumatic diseases

Indexed keywords

AORTA ARCH SYNDROME; AUTOLOGOUS STEM CELL TRANSPLANTATION; BEHCET DISEASE; BONE MARROW TRANSPLANTATION; BRAZIL; DEATH; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; REMISSION; REVIEW; RHEUMATIC DISEASE; STEM CELL MOBILIZATION; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 33645582805     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Voltarelli JC, Stracieri ABPL, Oliveira MCB, et al: Transplante de células-tronco hematopoéticas em doenças reumáticas -Parte 1: Experiência Internacional. Rev Bras Reumatol 45: 229-41, 2005.
2. Ferreira E, Ribeiro A, Bacal NS, et al: Transplante de células tronco periféricas autólogas no tratamento de doença auto-imune: remissão completa da anemia hemolítica por aglutinina a frio e concomitante vasculite. Boletim da Sociedade Brasileira de Hematologia e Hemoterapia 18 (supl): 191-O, 1996.
3. Marmont AM: New horizons in the treatment of autoimmune disease: Immunoablation and stem cell transplantation. Ann Rev Med 51: 115-34, 2000.
4. Moore J, Tyndall A, Brooks P: Stem cells in the aetiopathogenesis and therapy of rheumatic diseases. Best Practice Res Clin Rheumatol 15: 711-26, 2001.
5. Bingham SH, Snowden J, Morgan G, et al: High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases. Int Immunopharmacol 2: 399-414, 2002.
6. Gratwohl A, Passweg J, Gerber I, Tyndall A: Stem cell transplantation for autoimmune diseases. Best Practice Res Clin Haematol 14: 755-76, 2002.
7. Burt RK, Slavin S, Burns WH, Marmont A: Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? Blood 99: 768-84, 2002.
8. Furst DE: Stem cell transplantation for autoimmune disease: progress and problems. Curr Opin Rheumatol 14: 220-4, 2002.
9. Popat U, Krance R: Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective. Br J Haematol 126: 637-49, 2004.
10. Hough RE, Snowden JA, Wulfraat NM: Haematopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 128: 431-59, 2004.
11. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al: Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35: 869-79, 2005.
12. Tyndall A, Saccardi R: Hematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141: 1-9, 2005.
13. De Buys P, Khana D, Furst DE: Hemopoietic stem cell transplantation in rheumatic diseases- an update. Autoimmunity Rev 4: 442-9, 2005.
14. Voltarelli JC: Hematopoietic stem cell transplantation for autoimmune diseases in Brazil: Current status and future prospectives. Rev Bras Hematol Remoter 24: 206-11, 2002.
15. Voltarelli JC: Transplante de células tronco hematopoéticas para doenças auto-imunes no Brasil. Rev Bras Hematol Hemoter 24: 9-13, 2002.
16. Voltarelli JC, Ouyang J: Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: Current status and future prospectives. Bone Marrow Transplant 32: S69-71, 2003.
17. Von Mühlen CA, Hinterholz EL, Garicochea B, et al: Immunosuppression with cyclophosphamide and fludarabine, with support of autologous CD34+ stem cells, in the treatment of severe scleroderma. Rev Bras Reumatol 44: 169-174, 2004.
18. Voltarelli JC, Oliveira MCB, Stracieri ABPL, et al: Haematopoietic stem cell transplantation for refractory Takayasus's arteritis. Rheumatology 43: 1308-9, 2004.
19. Burt RK, Oyama Y, Traynor A, et al: Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring? Bone Marrow Transplantation 32: 565-7, 2003.
20. Fiehn C, Hensel M: High dose chemotherapy with haematopoietic stem cell transplantation in primary systemic vasculitis, Behçet's diseases and Sjogren's syndrome. In "Stem cell therapy for autoimmune diseases", edited by RK Burt & A Marmont, Landes Bioscience, Georgetown, TX, USA, 411-418, 2004.
21. Voltarelli JC, Stracieri AB, Rodrigues MC, et al: Outcome to autologous HSCT for severe and refractory autoimmune diseases in Brazil. Bone Marrow Transplantation 33 (Suppl 1): S145, 2004.
22. Voltarelli JC, Stracieri ABPL, Oliveira MCB, et al: Transplante autólogo de células tronco hematopoéticas para nefrite lúpica: Resultados brasileiros iniciais. J Bras Nefrol 25: 65-72, 2003.
23. Rosen O, Massenkeil G, Hiepe F, et al: Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSC): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant 58: 314-7, 2003.
24. Houssiau FA: Management of refractory systemic rheumatic diseases. Acta Clin Belg 58: 314-7, 2003.
25. Voltarelli JC: Autologous hematopoietic stem cell transplantation in type I diabetes mellitus. Rev Bras Hematol Hemoter 26: 43-5, 2004.
26. Voltarelli JC, Donadi EA, Martinez JAB, Vianna EO, Sarti W: Bronchial asthma and idiopathic pulmonary fibrosis as potential targets for hematopoietic stem cell transplantation. In "Stem cell therapy for autoimmune diseases", edited by RK Burt & A Marmont, Landes Bioscience, Georgetown, TX, USA, p. 457-67, 2004.
27. Voltarelli JC: Perspectivas de terapia celular na esclerose lateral amiotrófica. Rev Bras Hematol Hemoter 26: 155-6, 2004.
28. Thomas ED: Pros and cons of stem cell transplantation for autoimmune diseases. J. Rheumatol 24 (Supl 48): 100-2, 1997.
29. Potter M, Black C, Berger A: Bone marrow transplantation for autoimmune diseases: An interesting approach- but only for patients with few alternatives. Br Med J 318: 750-1, 1999.
30. Snowden JA, Nivison-Smith I, Biggs JC, et al: Risk taking in patients with rheumatoid arthritis: are the risks of hematopoietic stem cell transplantation acceptable? Rheumatology 38: 321-4, 1999.
31. Laxer RM, Harrison C: Bioethical issues in autologous stem cell transplantation in children and adults with arthritis. J Rheumatol 28: 2147-9, 2001.
32. McKendry RJ, Coyle D: Treatment related mortality versus quality of life- A balancing act. J Rheumatol 28: 688-90, 2001.
33. Stosor V, Zembower TR: Infection in the hematopoietic stem cell transplant recipient with autoimmune disease. In "Stem Cell Therapy for Autoimmune Diseases", ed. By RK Burt & AM Marmont, Landes Bioscience, p. 261-75, 2004.
34. Crippa F, Golmberg L, Carter RA, et al: Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 8: 281-9, 2002.
35. Nash RA, Dansey R, Storek J, et al: Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 9: 583-91, 2003.
36. Barron KS, Wallace C (eds): Autologous stem cell transplantation for pediatric rheumatic diseases. J Rheumatol 28: 2337-58, 2001.
37. Martin DK, Singer PA: Bone marrow transplant for rheumatoid arthritis: The costs of a cure. J Rheumatol 26: 1217-8, 1999.
38. + cells transplantation in China. Bone Marrow Transplant 31 (Suppl 1): S99, 2003.
39. Zhao J, Fu Y, Peng X: Autologous hematopoietic stem cell transplantation in the treatment of systemic lupus erythematosus. Bone Marrow Transplant 29 (Suppl 2): S15, 2002.
40. Chen J, Gu L-J, Xue H-L, et al: Primary report on the application of CD344+ autologous peripheral blood progenitor cell transplantation in the treatment of children with refractory systematic lupus erythematosus (SLE). Blood (Supl 1): 475b, 2002.
41. Lee T-L, Chan GC, Ha S-Y, et al: Autologous stem cell transplant in 3 patients with refractory autoimmune diseases. Blood 102: 484-5b, 2004.
42. Lisukov IA, Sizikova AS, Kulagin AD, et al: High dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus 13: 89-94, 2004.
43. Nagy K, Vertesi G, Marton G, Lombay B, et al: Allogenic HLA identical bone marrow transplantation in patient with juvenile idiopathic/chronic/ arthritis/JIA. Bone Marrow Transplantation 33 (Suppl 1): S 146, 2004.
44. Choi J-H, Ahn M-J, Oh H-S, et al: Autologous peripheral blood stem cell transplantation in refractory autoimmune diseases. Blood 102: 484b, 2004.
45. Fassas A, Anagnostopoulos A, Kazis A, et al: Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot trial. Bone Marrow Transplant 20: 631-8, 1997.
46. Kozak T, Havrdava E, Pitha J: High dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 25: 525-31, 2000.
47. Muraro PA, Martin R: Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 32 (Suppl 1): S41-S44, 2003.
48. Petri M, Jones RJ, Brodsky RA: High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 48: 166-73, 2003.
49. Drachman D, Brodsky R: High-dose cyclophosphamide for autoimmune neurologic disease. Curr Opin Oncol 17: 83-8, 2005.
50. Moyo VM, Smith D, Brodsky I, et al: High-dose cyclophosphamide for refractory autoimmune haemolytic anemia. Blood 100: 704-6, 2002.
51. Traynor AE, Schroeder J, Rosa RM, et al: Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and hematopoietic stem cell-transplantation: a phase I study. Lancet 356: 701-7, 2000.
52. Durez P, Toungouz M, Schandené L, et al: Remission and immune reconstitution after T-cell depleted stem-cell transplantation for rheumatoid arthritis. Lancet 352: 881, 1998.
53. Verburg RJ, Kruize AA, Van den Hoogen FHJ, et al: High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis. Arthritis & Rheumatism 44: 754-60, 2001.
54. Brinkman DMC, Ten Cate R, Vossen JM: Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis. Arthritis Rheum 46: 1121-4, 2002.
55. Ponchel F, Verburg RJ, Bingham SJ, et al: Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res Ther 7: R80-R92, 2005.
56. Thiel A, Alexander T, Schmidt CA, et al: Immune reconstitution after hematopoietic stem cell transplantation. In "Stem cell therapy for autoimmune diseases", edited by RK Burt & A Marmont, Landes Bioscience, Georgetown, TX, USA, p 206-222, 2004.
57. De Kleer IM, Brinkman DMC, Ferster A, et al: Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related mortality. Ann Rheum Dis 63: 1318-26, 2004.
58. Muraro P, Douek DC, Packer A, et al: Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201: 805-16, 2005.
59. Burt RK, Traynor AE, Oyama Y, Barr WG: Plasticity of hematopoietic stem cells: enough to induce tolerance and repair tissue? Arthritis Rheum 4: 855-8, 2002.
60. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J Med 348: 255-6, 2003.
61. Sykes M, Nikolic B: Treatment of severe autoimmune disease by stem cell transplantation. Nature 435: 620-7, 2005.
62. Farias KCRM, Oliveira MCB, Godoi DF, et al: Immune reconstitution and cytokine profile following autologous hematopoietic stem cell transplantation for autoimmune diseases. XXIX Meeting of the Brazilian Society for Immunology, Abstract TIG-9, p. 157, 2004.
63. Snowden JA, Biggs JC, Milliken ST, et al: A randomised, blinded, placebo-controlled, dose scalation study of the tolerability and efficacy of filgrastrim for haematopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 22: 1035-41, 1998.
64. Snowden JA, Biggs JC, Milliken ST, et al: A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 42: 2286-92, 1999.
65. Burt RK, Passas A, Snowden J, et al: Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 28: 1-12, 2001.
66. Burt RK, Kallunian K, Patel D, et al: The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis. Bone Marrow Transplant 34: 745-51, 2004.
67. Burt RK, Cohen B, Rose J, et al: Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol 62: 860-4, 2005.
68. Moore J, Brooks P, Milliken S, et al: A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 46: 2301-9, 2002.
69. Voltarelli JC, Couri CEB, Oliveira MC, et al: Autologous hematopoietic stem cell transplantation for type I diabetes mellitus. Blood 104: 391b, 2004.